NanoDx Collaborates with IBM Research on Sensors for Rapid Diagnostic Testing
NanoDx, Inc., has entered into a licensing agreement with IBM Research for use of its nanoscale sensors for accurate, rapid testing.
Read MorePosted by Chris Wolski | Jul 14, 2021 | Covid 19, POC Rapid Assays, Rapid Assays, Sepsis, Stroke |
NanoDx, Inc., has entered into a licensing agreement with IBM Research for use of its nanoscale sensors for accurate, rapid testing.
Read MorePosted by Chris Wolski | Jul 14, 2021 | Rapid Assays |
A new study has found that lateral flow tests detect COVID-19 with similar accuracy to laboratory-based PCR tests.
Read MorePosted by Melanie Hamilton-Basich | Jun 28, 2021 | Immunoassay Instrumentation |
The amended FDA EUA allows Quidel to market Sofia Q, its latest addition to the Sofia and Sofia 2 line of fluorescent immunoassay analyzers.
Read MorePosted by Chris Wolski | Jun 18, 2021 | Point-of-Care |
DCN Dx, an international provider of point-of-care diagnostics development, has announced completing its acquisition of PortaScience, Inc.
Read MorePosted by Melanie Hamilton-Basich | Jun 15, 2021 | Covid 19 |
Researchers discovered commercially available PCR tests can withstand the freeze-drying process, making them shelf-stable for up to 30 days and 122 degrees Fahrenheit, without sacrificing sensitivity and accuracy.
Read More